Sangamo Therapeutics
Patents, Design & Utilities

Last updated:

List of all Sangamo Therapeutics patents 110 in total

Status Patent
Grant
Utility: FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks External link
Filling date: 8 Sep 2025 Issue date: 24 Nov 2020
Grant
Utility: Liver-specific constructs and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 10 Nov 2020
Grant
Utility: Method of inactivating the IPK1 gene in corn External link
Filling date: 8 Sep 2025 Issue date: 10 Nov 2020
Grant
Utility: Compositions for linking DNA-binding domains and cleavage domains External link
Filling date: 8 Sep 2025 Issue date: 3 Nov 2020
Application
Utility: ENGINEERED TARGET SPECIFIC NUCLEASES External link
Filling date: 8 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: Modulators of Chromosome 9 Open Reading Frame 72 Gene Expression and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 29 Oct 2020
Grant
Utility: Nuclease-mediated regulation of gene expression External link
Filling date: 8 Sep 2025 Issue date: 20 Oct 2020
Application
Utility: COMPOSITIONS FOR LINKING DNA-BINDING DOMAINS AND CLEAVAGE DOMAINS External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: METHODS AND COMPOSITIONS FOR INCREASING RNA ACTIVITY IN A CELL External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: METHOD FOR THE TREATMENT OF BETA-THALASSEMIA External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: METHODS AND COMPOSITIONS FOR TARGETED CLEAVAGE AND RECOMBINATION External link
Filling date: 8 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: TARGETED DELETION OF CELLULAR DNA SEQUENCES External link
Filling date: 8 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: METHODS AND COMPOSITIONS FOR ENGINEERING IMMUNITY External link
Filling date: 8 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: COMPOSITIONS AND METHODS FOR PRODUCING RECOMBINANT AAV External link
Filling date: 8 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: METHODS AND COMPOSITIONS FOR TARGETED SINGLE-STRANDED CLEAVAGE AND TARGETED INTEGRATION External link
Filling date: 8 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE I External link
Filling date: 8 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: METHODS AND COMPOSITIONS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES External link
Filling date: 8 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: ENGINEERED CLEAVAGE HALF-DOMAINS External link
Filling date: 8 Sep 2025 Issue date: 23 Jul 2020
Grant
Utility: Methods and compositions for targeted single-stranded cleavage and targeted integration External link
Filling date: 8 Sep 2025 Issue date: 23 Jun 2020
Grant
Utility: Methods and compositions for targeted cleavage and recombination External link
Filling date: 8 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Targeted deletion of cellular DNA sequences External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Methods and compositions for treating trinucleotide repeat disorders External link
Filling date: 8 Sep 2025 Issue date: 12 May 2020
Grant
Utility: Artificial nucleases including engineered FokI cleavage half-domains External link
Filling date: 8 Sep 2025 Issue date: 5 May 2020
Application
Utility: REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES External link
Filling date: 8 Sep 2025 Issue date: 30 Apr 2020
Grant
Utility: Nuclease-mediated regulation of gene expression External link
Filling date: 8 Sep 2025 Issue date: 14 Apr 2020
Application
Utility: ENGINEERED GENETIC MODULATORS External link
Filling date: 8 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: METHODS AND COMPOSITIONS FOR MODULATION OF TAU PROTEINS External link
Filling date: 8 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING External link
Filling date: 8 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: FAD3 PERFORMANCE LOCI AND CORRESPONDING TARGET SITE SPECIFIC BINDING PROTEINS CAPABLE OF INDUCING TARGETED BREAKS External link
Filling date: 8 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: METHODS AND COMPOSITIONS FOR MODIFICATION OF A CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE External link
Filling date: 8 Sep 2025 Issue date: 12 Mar 2020
Application
Utility: TARGETED DISRUPTION OF THE MHC CELL RECEPTOR External link
Filling date: 8 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: METHODS AND COMPOSITIONS FOR INTEGRATION OF AN EXOGENOUS SEQUENCE WITHIN THE GENOME OF PLANTS External link
Filling date: 8 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: ENZYMATIC ASSAYS FOR QUANTIFYING THERAPY IN SUBJECTS WITH MUCOPOLYSACCHARIDOSIS TYPE I OR II External link
Filling date: 8 Sep 2025 Issue date: 5 Mar 2020
Grant
Utility: FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks External link
Filling date: 8 Sep 2025 Issue date: 3 Mar 2020
Application
Utility: ENGINEERED TARGET SPECIFIC BASE EDITORS External link
Filling date: 8 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE II External link
Filling date: 8 Sep 2025 Issue date: 27 Feb 2020
Grant
Utility: Regulation of gene expression using engineered nucleases External link
Filling date: 8 Sep 2025 Issue date: 18 Feb 2020
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 8 Sep 2025 Issue date: 30 Jan 2020
Grant
Utility: Compositions for linking DNA-binding domains and cleavage domains External link
Filling date: 8 Sep 2025 Issue date: 21 Jan 2020
Grant
Utility: FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks External link
Filling date: 8 Sep 2025 Issue date: 7 Jan 2020
Application
Utility: HTT REPRESSORS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 2 Jan 2020
Grant
Utility: Targeted disruption of the MHC cell receptor External link
Filling date: 8 Sep 2025 Issue date: 10 Dec 2019
Application
Utility: DELIVERY OF TARGET SPECIFIC NUCLEASES External link
Filling date: 8 Sep 2025 Issue date: 5 Dec 2019
Grant
Utility: Delivery methods and compositions for nuclease-mediated genome engineering External link
Filling date: 8 Sep 2025 Issue date: 3 Dec 2019
Application
Utility: METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION External link
Filling date: 8 Sep 2025 Issue date: 21 Nov 2019
Application
Utility: B-CELL ENGINEERING External link
Filling date: 8 Sep 2025 Issue date: 21 Nov 2019
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA External link
Filling date: 8 Sep 2025 Issue date: 14 Nov 2019
Grant
Utility: Methods and compositions for treating Huntington's disease External link
Filling date: 8 Sep 2025 Issue date: 12 Nov 2019
Application
Utility: TARGETED MODIFICATION OF MALATE DEHYDROGENASE External link
Filling date: 8 Sep 2025 Issue date: 31 Oct 2019

Showing 50 to 100 of 110 patents.